Exercise Therapy Consultants, Inc - Medicare Physical Therapist in Belton, MO

Exercise Therapy Consultants, Inc is a medicare enrolled "Physical Therapist" provider in Belton, Missouri. Their current practice location is 924 N Scott Ave, Belton, Missouri. You can reach out to their office (for appointments etc.) via phone at (816) 331-9111.

Exercise Therapy Consultants, Inc is licensed to practice in Missouri (license number ) and it also participates in the medicare program. Exercise Therapy Consultants, Inc is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1962414250.

Contact Information

Exercise Therapy Consultants, Inc
924 N Scott Ave,
Belton, MO 64012-1739
(816) 331-9111
(816) 348-0492



Healthcare Provider's Profile

Full NameExercise Therapy Consultants, Inc
TypeFacility
SpecialityPhysical Therapist
Location924 N Scott Ave, Belton, Missouri
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1962414250
  • Provider Enumeration Date: 08/13/2006
  • Last Update Date: 07/21/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 1557269255
  • Enrollment ID: O20170929003392

Medical Identifiers

Medical identifiers for Exercise Therapy Consultants, Inc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1962414250NPI-NPPES
25691019OtherMOBCBS PROVIDER #

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
225100000XPhysical Therapist (Missouri)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Exercise Therapy Consultants, Inc acts as a billing entity for following providers:
Provider NameJanet Sheri Stone
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1851303176
PECOS PAC ID: 1456259167
Enrollment ID: I20051103000066

News Archive

Aesculap plans to develop neurostimulators for lowering high blood pressure

The Tuttlingen medical technology company Aesculap AG has founded the Freiburg startup neuroloop GmbH in cooperation with the University of Freiburg and the Freiburg University Medical Center. Building on research work from a team led by Prof. Dr. Thomas Stieglitz at the university's Department of Microsystems Engineering (IMTEK) and a research group at the university medical center, the company plans to develop neurostimulators that will be capable among other things of lowering high blood pressure.

Vision Express advises Britons to be 'sun safe' when choosing eyewear

Britons are putting their sight at risk – potentially exposing themselves to cataracts and macular degeneration – by choosing vanity over UV protection when buying sunglasses, new research from Vision Express has revealed.

Kent med-tech company celebrates International Women's Day

International Women's Day celebrates the economic, cultural and political achievements of women as well as building and accelerating women's equality.

Genetic link to depression: New avenues for therapy

Yale University scientists have found a gene that appears to play a key role in the onset of depression. This could mean new avenues of therapy for the disease. The gene in question is called MKP-1 and was identified after comparing the genetic codes of 21 deceased people who had been diagnosed with depression with those of 18 otherwise healthy individuals. The findings were published in the journal Nature Medicine on 17th of October.

Read more Medical News

› Verified 7 days ago

Provider NameJennifer L Mattson
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1972707461
PECOS PAC ID: 8426157645
Enrollment ID: I20081009000400

News Archive

Aesculap plans to develop neurostimulators for lowering high blood pressure

The Tuttlingen medical technology company Aesculap AG has founded the Freiburg startup neuroloop GmbH in cooperation with the University of Freiburg and the Freiburg University Medical Center. Building on research work from a team led by Prof. Dr. Thomas Stieglitz at the university's Department of Microsystems Engineering (IMTEK) and a research group at the university medical center, the company plans to develop neurostimulators that will be capable among other things of lowering high blood pressure.

Vision Express advises Britons to be 'sun safe' when choosing eyewear

Britons are putting their sight at risk – potentially exposing themselves to cataracts and macular degeneration – by choosing vanity over UV protection when buying sunglasses, new research from Vision Express has revealed.

Kent med-tech company celebrates International Women's Day

International Women's Day celebrates the economic, cultural and political achievements of women as well as building and accelerating women's equality.

Genetic link to depression: New avenues for therapy

Yale University scientists have found a gene that appears to play a key role in the onset of depression. This could mean new avenues of therapy for the disease. The gene in question is called MKP-1 and was identified after comparing the genetic codes of 21 deceased people who had been diagnosed with depression with those of 18 otherwise healthy individuals. The findings were published in the journal Nature Medicine on 17th of October.

Read more Medical News

› Verified 7 days ago

Provider NameSarah Gardner
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1194130591
PECOS PAC ID: 7315164803
Enrollment ID: I20140825002436

News Archive

Aesculap plans to develop neurostimulators for lowering high blood pressure

The Tuttlingen medical technology company Aesculap AG has founded the Freiburg startup neuroloop GmbH in cooperation with the University of Freiburg and the Freiburg University Medical Center. Building on research work from a team led by Prof. Dr. Thomas Stieglitz at the university's Department of Microsystems Engineering (IMTEK) and a research group at the university medical center, the company plans to develop neurostimulators that will be capable among other things of lowering high blood pressure.

Vision Express advises Britons to be 'sun safe' when choosing eyewear

Britons are putting their sight at risk – potentially exposing themselves to cataracts and macular degeneration – by choosing vanity over UV protection when buying sunglasses, new research from Vision Express has revealed.

Kent med-tech company celebrates International Women's Day

International Women's Day celebrates the economic, cultural and political achievements of women as well as building and accelerating women's equality.

Genetic link to depression: New avenues for therapy

Yale University scientists have found a gene that appears to play a key role in the onset of depression. This could mean new avenues of therapy for the disease. The gene in question is called MKP-1 and was identified after comparing the genetic codes of 21 deceased people who had been diagnosed with depression with those of 18 otherwise healthy individuals. The findings were published in the journal Nature Medicine on 17th of October.

Read more Medical News

› Verified 7 days ago

Provider NameKrista E Johnson
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1902269681
PECOS PAC ID: 7012206394
Enrollment ID: I20160630001302

News Archive

Aesculap plans to develop neurostimulators for lowering high blood pressure

The Tuttlingen medical technology company Aesculap AG has founded the Freiburg startup neuroloop GmbH in cooperation with the University of Freiburg and the Freiburg University Medical Center. Building on research work from a team led by Prof. Dr. Thomas Stieglitz at the university's Department of Microsystems Engineering (IMTEK) and a research group at the university medical center, the company plans to develop neurostimulators that will be capable among other things of lowering high blood pressure.

Vision Express advises Britons to be 'sun safe' when choosing eyewear

Britons are putting their sight at risk – potentially exposing themselves to cataracts and macular degeneration – by choosing vanity over UV protection when buying sunglasses, new research from Vision Express has revealed.

Kent med-tech company celebrates International Women's Day

International Women's Day celebrates the economic, cultural and political achievements of women as well as building and accelerating women's equality.

Genetic link to depression: New avenues for therapy

Yale University scientists have found a gene that appears to play a key role in the onset of depression. This could mean new avenues of therapy for the disease. The gene in question is called MKP-1 and was identified after comparing the genetic codes of 21 deceased people who had been diagnosed with depression with those of 18 otherwise healthy individuals. The findings were published in the journal Nature Medicine on 17th of October.

Read more Medical News

› Verified 7 days ago

Provider NameChristina K Middlebusher
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1851736623
PECOS PAC ID: 8123371754
Enrollment ID: I20181030000698

News Archive

Aesculap plans to develop neurostimulators for lowering high blood pressure

The Tuttlingen medical technology company Aesculap AG has founded the Freiburg startup neuroloop GmbH in cooperation with the University of Freiburg and the Freiburg University Medical Center. Building on research work from a team led by Prof. Dr. Thomas Stieglitz at the university's Department of Microsystems Engineering (IMTEK) and a research group at the university medical center, the company plans to develop neurostimulators that will be capable among other things of lowering high blood pressure.

Vision Express advises Britons to be 'sun safe' when choosing eyewear

Britons are putting their sight at risk – potentially exposing themselves to cataracts and macular degeneration – by choosing vanity over UV protection when buying sunglasses, new research from Vision Express has revealed.

Kent med-tech company celebrates International Women's Day

International Women's Day celebrates the economic, cultural and political achievements of women as well as building and accelerating women's equality.

Genetic link to depression: New avenues for therapy

Yale University scientists have found a gene that appears to play a key role in the onset of depression. This could mean new avenues of therapy for the disease. The gene in question is called MKP-1 and was identified after comparing the genetic codes of 21 deceased people who had been diagnosed with depression with those of 18 otherwise healthy individuals. The findings were published in the journal Nature Medicine on 17th of October.

Read more Medical News

› Verified 7 days ago

Provider NameTaylor J Ballantyne
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1952961195
PECOS PAC ID: 2860727013
Enrollment ID: I20190711000197

News Archive

Aesculap plans to develop neurostimulators for lowering high blood pressure

The Tuttlingen medical technology company Aesculap AG has founded the Freiburg startup neuroloop GmbH in cooperation with the University of Freiburg and the Freiburg University Medical Center. Building on research work from a team led by Prof. Dr. Thomas Stieglitz at the university's Department of Microsystems Engineering (IMTEK) and a research group at the university medical center, the company plans to develop neurostimulators that will be capable among other things of lowering high blood pressure.

Vision Express advises Britons to be 'sun safe' when choosing eyewear

Britons are putting their sight at risk – potentially exposing themselves to cataracts and macular degeneration – by choosing vanity over UV protection when buying sunglasses, new research from Vision Express has revealed.

Kent med-tech company celebrates International Women's Day

International Women's Day celebrates the economic, cultural and political achievements of women as well as building and accelerating women's equality.

Genetic link to depression: New avenues for therapy

Yale University scientists have found a gene that appears to play a key role in the onset of depression. This could mean new avenues of therapy for the disease. The gene in question is called MKP-1 and was identified after comparing the genetic codes of 21 deceased people who had been diagnosed with depression with those of 18 otherwise healthy individuals. The findings were published in the journal Nature Medicine on 17th of October.

Read more Medical News

› Verified 7 days ago

Provider NameJenna M Aldridge
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1669028460
PECOS PAC ID: 7113256074
Enrollment ID: I20190903001465

News Archive

Aesculap plans to develop neurostimulators for lowering high blood pressure

The Tuttlingen medical technology company Aesculap AG has founded the Freiburg startup neuroloop GmbH in cooperation with the University of Freiburg and the Freiburg University Medical Center. Building on research work from a team led by Prof. Dr. Thomas Stieglitz at the university's Department of Microsystems Engineering (IMTEK) and a research group at the university medical center, the company plans to develop neurostimulators that will be capable among other things of lowering high blood pressure.

Vision Express advises Britons to be 'sun safe' when choosing eyewear

Britons are putting their sight at risk – potentially exposing themselves to cataracts and macular degeneration – by choosing vanity over UV protection when buying sunglasses, new research from Vision Express has revealed.

Kent med-tech company celebrates International Women's Day

International Women's Day celebrates the economic, cultural and political achievements of women as well as building and accelerating women's equality.

Genetic link to depression: New avenues for therapy

Yale University scientists have found a gene that appears to play a key role in the onset of depression. This could mean new avenues of therapy for the disease. The gene in question is called MKP-1 and was identified after comparing the genetic codes of 21 deceased people who had been diagnosed with depression with those of 18 otherwise healthy individuals. The findings were published in the journal Nature Medicine on 17th of October.

Read more Medical News

› Verified 7 days ago

Provider NameNathan C Veenis
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1295396497
PECOS PAC ID: 3779818414
Enrollment ID: I20190906003115

News Archive

Aesculap plans to develop neurostimulators for lowering high blood pressure

The Tuttlingen medical technology company Aesculap AG has founded the Freiburg startup neuroloop GmbH in cooperation with the University of Freiburg and the Freiburg University Medical Center. Building on research work from a team led by Prof. Dr. Thomas Stieglitz at the university's Department of Microsystems Engineering (IMTEK) and a research group at the university medical center, the company plans to develop neurostimulators that will be capable among other things of lowering high blood pressure.

Vision Express advises Britons to be 'sun safe' when choosing eyewear

Britons are putting their sight at risk – potentially exposing themselves to cataracts and macular degeneration – by choosing vanity over UV protection when buying sunglasses, new research from Vision Express has revealed.

Kent med-tech company celebrates International Women's Day

International Women's Day celebrates the economic, cultural and political achievements of women as well as building and accelerating women's equality.

Genetic link to depression: New avenues for therapy

Yale University scientists have found a gene that appears to play a key role in the onset of depression. This could mean new avenues of therapy for the disease. The gene in question is called MKP-1 and was identified after comparing the genetic codes of 21 deceased people who had been diagnosed with depression with those of 18 otherwise healthy individuals. The findings were published in the journal Nature Medicine on 17th of October.

Read more Medical News

› Verified 7 days ago

Provider NameEric D Johnson
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1396213849
PECOS PAC ID: 7719314087
Enrollment ID: I20200226001007

News Archive

Aesculap plans to develop neurostimulators for lowering high blood pressure

The Tuttlingen medical technology company Aesculap AG has founded the Freiburg startup neuroloop GmbH in cooperation with the University of Freiburg and the Freiburg University Medical Center. Building on research work from a team led by Prof. Dr. Thomas Stieglitz at the university's Department of Microsystems Engineering (IMTEK) and a research group at the university medical center, the company plans to develop neurostimulators that will be capable among other things of lowering high blood pressure.

Vision Express advises Britons to be 'sun safe' when choosing eyewear

Britons are putting their sight at risk – potentially exposing themselves to cataracts and macular degeneration – by choosing vanity over UV protection when buying sunglasses, new research from Vision Express has revealed.

Kent med-tech company celebrates International Women's Day

International Women's Day celebrates the economic, cultural and political achievements of women as well as building and accelerating women's equality.

Genetic link to depression: New avenues for therapy

Yale University scientists have found a gene that appears to play a key role in the onset of depression. This could mean new avenues of therapy for the disease. The gene in question is called MKP-1 and was identified after comparing the genetic codes of 21 deceased people who had been diagnosed with depression with those of 18 otherwise healthy individuals. The findings were published in the journal Nature Medicine on 17th of October.

Read more Medical News

› Verified 7 days ago

Provider NameMegan Burns
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1780112219
PECOS PAC ID: 1153743935
Enrollment ID: I20200624001723

News Archive

Aesculap plans to develop neurostimulators for lowering high blood pressure

The Tuttlingen medical technology company Aesculap AG has founded the Freiburg startup neuroloop GmbH in cooperation with the University of Freiburg and the Freiburg University Medical Center. Building on research work from a team led by Prof. Dr. Thomas Stieglitz at the university's Department of Microsystems Engineering (IMTEK) and a research group at the university medical center, the company plans to develop neurostimulators that will be capable among other things of lowering high blood pressure.

Vision Express advises Britons to be 'sun safe' when choosing eyewear

Britons are putting their sight at risk – potentially exposing themselves to cataracts and macular degeneration – by choosing vanity over UV protection when buying sunglasses, new research from Vision Express has revealed.

Kent med-tech company celebrates International Women's Day

International Women's Day celebrates the economic, cultural and political achievements of women as well as building and accelerating women's equality.

Genetic link to depression: New avenues for therapy

Yale University scientists have found a gene that appears to play a key role in the onset of depression. This could mean new avenues of therapy for the disease. The gene in question is called MKP-1 and was identified after comparing the genetic codes of 21 deceased people who had been diagnosed with depression with those of 18 otherwise healthy individuals. The findings were published in the journal Nature Medicine on 17th of October.

Read more Medical News

› Verified 7 days ago

Provider NameKevin T Fetsch
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1265056949
PECOS PAC ID: 1759704158
Enrollment ID: I20200701002627

News Archive

Aesculap plans to develop neurostimulators for lowering high blood pressure

The Tuttlingen medical technology company Aesculap AG has founded the Freiburg startup neuroloop GmbH in cooperation with the University of Freiburg and the Freiburg University Medical Center. Building on research work from a team led by Prof. Dr. Thomas Stieglitz at the university's Department of Microsystems Engineering (IMTEK) and a research group at the university medical center, the company plans to develop neurostimulators that will be capable among other things of lowering high blood pressure.

Vision Express advises Britons to be 'sun safe' when choosing eyewear

Britons are putting their sight at risk – potentially exposing themselves to cataracts and macular degeneration – by choosing vanity over UV protection when buying sunglasses, new research from Vision Express has revealed.

Kent med-tech company celebrates International Women's Day

International Women's Day celebrates the economic, cultural and political achievements of women as well as building and accelerating women's equality.

Genetic link to depression: New avenues for therapy

Yale University scientists have found a gene that appears to play a key role in the onset of depression. This could mean new avenues of therapy for the disease. The gene in question is called MKP-1 and was identified after comparing the genetic codes of 21 deceased people who had been diagnosed with depression with those of 18 otherwise healthy individuals. The findings were published in the journal Nature Medicine on 17th of October.

Read more Medical News

› Verified 7 days ago

Provider NameRichard W Sanders
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1174119648
PECOS PAC ID: 2567874118
Enrollment ID: I20201223002169

News Archive

Aesculap plans to develop neurostimulators for lowering high blood pressure

The Tuttlingen medical technology company Aesculap AG has founded the Freiburg startup neuroloop GmbH in cooperation with the University of Freiburg and the Freiburg University Medical Center. Building on research work from a team led by Prof. Dr. Thomas Stieglitz at the university's Department of Microsystems Engineering (IMTEK) and a research group at the university medical center, the company plans to develop neurostimulators that will be capable among other things of lowering high blood pressure.

Vision Express advises Britons to be 'sun safe' when choosing eyewear

Britons are putting their sight at risk – potentially exposing themselves to cataracts and macular degeneration – by choosing vanity over UV protection when buying sunglasses, new research from Vision Express has revealed.

Kent med-tech company celebrates International Women's Day

International Women's Day celebrates the economic, cultural and political achievements of women as well as building and accelerating women's equality.

Genetic link to depression: New avenues for therapy

Yale University scientists have found a gene that appears to play a key role in the onset of depression. This could mean new avenues of therapy for the disease. The gene in question is called MKP-1 and was identified after comparing the genetic codes of 21 deceased people who had been diagnosed with depression with those of 18 otherwise healthy individuals. The findings were published in the journal Nature Medicine on 17th of October.

Read more Medical News

› Verified 7 days ago

Provider NameAshley C Martin
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1700476579
PECOS PAC ID: 2860807955
Enrollment ID: I20210223002611

News Archive

Aesculap plans to develop neurostimulators for lowering high blood pressure

The Tuttlingen medical technology company Aesculap AG has founded the Freiburg startup neuroloop GmbH in cooperation with the University of Freiburg and the Freiburg University Medical Center. Building on research work from a team led by Prof. Dr. Thomas Stieglitz at the university's Department of Microsystems Engineering (IMTEK) and a research group at the university medical center, the company plans to develop neurostimulators that will be capable among other things of lowering high blood pressure.

Vision Express advises Britons to be 'sun safe' when choosing eyewear

Britons are putting their sight at risk – potentially exposing themselves to cataracts and macular degeneration – by choosing vanity over UV protection when buying sunglasses, new research from Vision Express has revealed.

Kent med-tech company celebrates International Women's Day

International Women's Day celebrates the economic, cultural and political achievements of women as well as building and accelerating women's equality.

Genetic link to depression: New avenues for therapy

Yale University scientists have found a gene that appears to play a key role in the onset of depression. This could mean new avenues of therapy for the disease. The gene in question is called MKP-1 and was identified after comparing the genetic codes of 21 deceased people who had been diagnosed with depression with those of 18 otherwise healthy individuals. The findings were published in the journal Nature Medicine on 17th of October.

Read more Medical News

› Verified 7 days ago

Provider NameKara Mierzejewski
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1972046365
PECOS PAC ID: 3678981735
Enrollment ID: I20210409001768

News Archive

Aesculap plans to develop neurostimulators for lowering high blood pressure

The Tuttlingen medical technology company Aesculap AG has founded the Freiburg startup neuroloop GmbH in cooperation with the University of Freiburg and the Freiburg University Medical Center. Building on research work from a team led by Prof. Dr. Thomas Stieglitz at the university's Department of Microsystems Engineering (IMTEK) and a research group at the university medical center, the company plans to develop neurostimulators that will be capable among other things of lowering high blood pressure.

Vision Express advises Britons to be 'sun safe' when choosing eyewear

Britons are putting their sight at risk – potentially exposing themselves to cataracts and macular degeneration – by choosing vanity over UV protection when buying sunglasses, new research from Vision Express has revealed.

Kent med-tech company celebrates International Women's Day

International Women's Day celebrates the economic, cultural and political achievements of women as well as building and accelerating women's equality.

Genetic link to depression: New avenues for therapy

Yale University scientists have found a gene that appears to play a key role in the onset of depression. This could mean new avenues of therapy for the disease. The gene in question is called MKP-1 and was identified after comparing the genetic codes of 21 deceased people who had been diagnosed with depression with those of 18 otherwise healthy individuals. The findings were published in the journal Nature Medicine on 17th of October.

Read more Medical News

› Verified 7 days ago

Provider NameAustin M Shrout
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1609443944
PECOS PAC ID: 1355747155
Enrollment ID: I20210902000446

News Archive

Aesculap plans to develop neurostimulators for lowering high blood pressure

The Tuttlingen medical technology company Aesculap AG has founded the Freiburg startup neuroloop GmbH in cooperation with the University of Freiburg and the Freiburg University Medical Center. Building on research work from a team led by Prof. Dr. Thomas Stieglitz at the university's Department of Microsystems Engineering (IMTEK) and a research group at the university medical center, the company plans to develop neurostimulators that will be capable among other things of lowering high blood pressure.

Vision Express advises Britons to be 'sun safe' when choosing eyewear

Britons are putting their sight at risk – potentially exposing themselves to cataracts and macular degeneration – by choosing vanity over UV protection when buying sunglasses, new research from Vision Express has revealed.

Kent med-tech company celebrates International Women's Day

International Women's Day celebrates the economic, cultural and political achievements of women as well as building and accelerating women's equality.

Genetic link to depression: New avenues for therapy

Yale University scientists have found a gene that appears to play a key role in the onset of depression. This could mean new avenues of therapy for the disease. The gene in question is called MKP-1 and was identified after comparing the genetic codes of 21 deceased people who had been diagnosed with depression with those of 18 otherwise healthy individuals. The findings were published in the journal Nature Medicine on 17th of October.

Read more Medical News

› Verified 7 days ago

Provider NameDavid Aurand
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1558955039
PECOS PAC ID: 5496155053
Enrollment ID: I20210920000706

News Archive

Aesculap plans to develop neurostimulators for lowering high blood pressure

The Tuttlingen medical technology company Aesculap AG has founded the Freiburg startup neuroloop GmbH in cooperation with the University of Freiburg and the Freiburg University Medical Center. Building on research work from a team led by Prof. Dr. Thomas Stieglitz at the university's Department of Microsystems Engineering (IMTEK) and a research group at the university medical center, the company plans to develop neurostimulators that will be capable among other things of lowering high blood pressure.

Vision Express advises Britons to be 'sun safe' when choosing eyewear

Britons are putting their sight at risk – potentially exposing themselves to cataracts and macular degeneration – by choosing vanity over UV protection when buying sunglasses, new research from Vision Express has revealed.

Kent med-tech company celebrates International Women's Day

International Women's Day celebrates the economic, cultural and political achievements of women as well as building and accelerating women's equality.

Genetic link to depression: New avenues for therapy

Yale University scientists have found a gene that appears to play a key role in the onset of depression. This could mean new avenues of therapy for the disease. The gene in question is called MKP-1 and was identified after comparing the genetic codes of 21 deceased people who had been diagnosed with depression with those of 18 otherwise healthy individuals. The findings were published in the journal Nature Medicine on 17th of October.

Read more Medical News

› Verified 7 days ago

Provider NameKayla M Lapointe
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1740943646
PECOS PAC ID: 8123416088
Enrollment ID: I20211026000807

News Archive

Aesculap plans to develop neurostimulators for lowering high blood pressure

The Tuttlingen medical technology company Aesculap AG has founded the Freiburg startup neuroloop GmbH in cooperation with the University of Freiburg and the Freiburg University Medical Center. Building on research work from a team led by Prof. Dr. Thomas Stieglitz at the university's Department of Microsystems Engineering (IMTEK) and a research group at the university medical center, the company plans to develop neurostimulators that will be capable among other things of lowering high blood pressure.

Vision Express advises Britons to be 'sun safe' when choosing eyewear

Britons are putting their sight at risk – potentially exposing themselves to cataracts and macular degeneration – by choosing vanity over UV protection when buying sunglasses, new research from Vision Express has revealed.

Kent med-tech company celebrates International Women's Day

International Women's Day celebrates the economic, cultural and political achievements of women as well as building and accelerating women's equality.

Genetic link to depression: New avenues for therapy

Yale University scientists have found a gene that appears to play a key role in the onset of depression. This could mean new avenues of therapy for the disease. The gene in question is called MKP-1 and was identified after comparing the genetic codes of 21 deceased people who had been diagnosed with depression with those of 18 otherwise healthy individuals. The findings were published in the journal Nature Medicine on 17th of October.

Read more Medical News

› Verified 7 days ago

Provider NameCourtney D Simon
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1174006613
PECOS PAC ID: 3779914908
Enrollment ID: I20221114002909

News Archive

Aesculap plans to develop neurostimulators for lowering high blood pressure

The Tuttlingen medical technology company Aesculap AG has founded the Freiburg startup neuroloop GmbH in cooperation with the University of Freiburg and the Freiburg University Medical Center. Building on research work from a team led by Prof. Dr. Thomas Stieglitz at the university's Department of Microsystems Engineering (IMTEK) and a research group at the university medical center, the company plans to develop neurostimulators that will be capable among other things of lowering high blood pressure.

Vision Express advises Britons to be 'sun safe' when choosing eyewear

Britons are putting their sight at risk – potentially exposing themselves to cataracts and macular degeneration – by choosing vanity over UV protection when buying sunglasses, new research from Vision Express has revealed.

Kent med-tech company celebrates International Women's Day

International Women's Day celebrates the economic, cultural and political achievements of women as well as building and accelerating women's equality.

Genetic link to depression: New avenues for therapy

Yale University scientists have found a gene that appears to play a key role in the onset of depression. This could mean new avenues of therapy for the disease. The gene in question is called MKP-1 and was identified after comparing the genetic codes of 21 deceased people who had been diagnosed with depression with those of 18 otherwise healthy individuals. The findings were published in the journal Nature Medicine on 17th of October.

Read more Medical News

› Verified 7 days ago

Provider NameNoelle L Teemant
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1700195955
PECOS PAC ID: 2567683543
Enrollment ID: I20221130002939

News Archive

Aesculap plans to develop neurostimulators for lowering high blood pressure

The Tuttlingen medical technology company Aesculap AG has founded the Freiburg startup neuroloop GmbH in cooperation with the University of Freiburg and the Freiburg University Medical Center. Building on research work from a team led by Prof. Dr. Thomas Stieglitz at the university's Department of Microsystems Engineering (IMTEK) and a research group at the university medical center, the company plans to develop neurostimulators that will be capable among other things of lowering high blood pressure.

Vision Express advises Britons to be 'sun safe' when choosing eyewear

Britons are putting their sight at risk – potentially exposing themselves to cataracts and macular degeneration – by choosing vanity over UV protection when buying sunglasses, new research from Vision Express has revealed.

Kent med-tech company celebrates International Women's Day

International Women's Day celebrates the economic, cultural and political achievements of women as well as building and accelerating women's equality.

Genetic link to depression: New avenues for therapy

Yale University scientists have found a gene that appears to play a key role in the onset of depression. This could mean new avenues of therapy for the disease. The gene in question is called MKP-1 and was identified after comparing the genetic codes of 21 deceased people who had been diagnosed with depression with those of 18 otherwise healthy individuals. The findings were published in the journal Nature Medicine on 17th of October.

Read more Medical News

› Verified 7 days ago

Provider NameVasiliy Birdsong
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1932888724
PECOS PAC ID: 2264894914
Enrollment ID: I20230814001221

News Archive

Aesculap plans to develop neurostimulators for lowering high blood pressure

The Tuttlingen medical technology company Aesculap AG has founded the Freiburg startup neuroloop GmbH in cooperation with the University of Freiburg and the Freiburg University Medical Center. Building on research work from a team led by Prof. Dr. Thomas Stieglitz at the university's Department of Microsystems Engineering (IMTEK) and a research group at the university medical center, the company plans to develop neurostimulators that will be capable among other things of lowering high blood pressure.

Vision Express advises Britons to be 'sun safe' when choosing eyewear

Britons are putting their sight at risk – potentially exposing themselves to cataracts and macular degeneration – by choosing vanity over UV protection when buying sunglasses, new research from Vision Express has revealed.

Kent med-tech company celebrates International Women's Day

International Women's Day celebrates the economic, cultural and political achievements of women as well as building and accelerating women's equality.

Genetic link to depression: New avenues for therapy

Yale University scientists have found a gene that appears to play a key role in the onset of depression. This could mean new avenues of therapy for the disease. The gene in question is called MKP-1 and was identified after comparing the genetic codes of 21 deceased people who had been diagnosed with depression with those of 18 otherwise healthy individuals. The findings were published in the journal Nature Medicine on 17th of October.

Read more Medical News

› Verified 7 days ago

Provider NameAubrey Bartel
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1316626039
PECOS PAC ID: 2668835216
Enrollment ID: I20230829004052

News Archive

Aesculap plans to develop neurostimulators for lowering high blood pressure

The Tuttlingen medical technology company Aesculap AG has founded the Freiburg startup neuroloop GmbH in cooperation with the University of Freiburg and the Freiburg University Medical Center. Building on research work from a team led by Prof. Dr. Thomas Stieglitz at the university's Department of Microsystems Engineering (IMTEK) and a research group at the university medical center, the company plans to develop neurostimulators that will be capable among other things of lowering high blood pressure.

Vision Express advises Britons to be 'sun safe' when choosing eyewear

Britons are putting their sight at risk – potentially exposing themselves to cataracts and macular degeneration – by choosing vanity over UV protection when buying sunglasses, new research from Vision Express has revealed.

Kent med-tech company celebrates International Women's Day

International Women's Day celebrates the economic, cultural and political achievements of women as well as building and accelerating women's equality.

Genetic link to depression: New avenues for therapy

Yale University scientists have found a gene that appears to play a key role in the onset of depression. This could mean new avenues of therapy for the disease. The gene in question is called MKP-1 and was identified after comparing the genetic codes of 21 deceased people who had been diagnosed with depression with those of 18 otherwise healthy individuals. The findings were published in the journal Nature Medicine on 17th of October.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Exercise Therapy Consultants, Inc is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Exercise Therapy Consultants, Inc
Po Box 320,
Belton, MO 64012-0320

Ph: (816) 331-9111
Exercise Therapy Consultants, Inc
924 N Scott Ave,
Belton, MO 64012-1739

Ph: (816) 331-9111

News Archive

Aesculap plans to develop neurostimulators for lowering high blood pressure

The Tuttlingen medical technology company Aesculap AG has founded the Freiburg startup neuroloop GmbH in cooperation with the University of Freiburg and the Freiburg University Medical Center. Building on research work from a team led by Prof. Dr. Thomas Stieglitz at the university's Department of Microsystems Engineering (IMTEK) and a research group at the university medical center, the company plans to develop neurostimulators that will be capable among other things of lowering high blood pressure.

Vision Express advises Britons to be 'sun safe' when choosing eyewear

Britons are putting their sight at risk – potentially exposing themselves to cataracts and macular degeneration – by choosing vanity over UV protection when buying sunglasses, new research from Vision Express has revealed.

Kent med-tech company celebrates International Women's Day

International Women's Day celebrates the economic, cultural and political achievements of women as well as building and accelerating women's equality.

Genetic link to depression: New avenues for therapy

Yale University scientists have found a gene that appears to play a key role in the onset of depression. This could mean new avenues of therapy for the disease. The gene in question is called MKP-1 and was identified after comparing the genetic codes of 21 deceased people who had been diagnosed with depression with those of 18 otherwise healthy individuals. The findings were published in the journal Nature Medicine on 17th of October.

Read more News

› Verified 7 days ago


Physical Therapist in Belton, MO

Julia M Profit, PT
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 924 N Scott Ave, Belton, MO 64012
Phone: 816-331-9111    Fax: 816-348-0492
Mason Gahan, DPT
Physical Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 1825 E North Ave, Belton, MO 64012
Phone: 816-775-4747    
Kelsey Nicole Anderson, PT, DPT
Physical Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 17134 Bel Ray Pl, Belton, MO 64012
Phone: 816-318-0434    Fax: 816-318-0437
Dr. Benjamin Theodore Horowitz, DPT
Physical Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 107 Bernard Dr, Belton, MO 64012
Phone: 816-331-7848    
Benjamin Brian Clark, DPT
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 7909 Forrest Ave, Belton, MO 64012
Phone: 816-738-1666    
Allison Ann Hilboldt, PT, DPT
Physical Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 17134 Bel Ray Pl, Belton, MO 64012
Phone: 816-318-0434    Fax: 816-318-0437
Timothy Ryan Turner, PT, DPT
Physical Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 17134 Bel Ray Pl, Belton, MO 64012
Phone: 816-318-0434    Fax: 816-318-0437

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.